When someone like David Sinclair changes his longevity protocol, most people immediately want the list.
What did he stop taking?
What did he add?
What stayed the same?
What should I buy now?
That reaction makes sense. Longevity is confusing, expensive, and full of strong opinions. So when a well-known scientist or biohacker updates their routine, it can feel like we’re getting a peek at the answer key.
But that’s also where the trap starts.
Because the list is not the lesson.
The bigger question is not just what changed in Sinclair’s protocol. The bigger question is what we’re supposed to do when someone we trusted changes their mind.
That’s the real issue we unpack in the video.
For us, this one landed differently because Tony recently started taking Metformin. Not because he needed another pill bottle on the counter. Not because of one headline. But because people in the longevity space had made a serious case for it.
Metformin isn’t some random internet supplement. It’s a well-known medication with a long history, especially around blood sugar and metabolic health. That gave it a different kind of weight than a lot of things in the biohacking world.
So when Sinclair appears to move away from Metformin, the question becomes personal.
Not: “Is Metformin good or bad?”
Not: “Should everyone take it or stop taking it?”
And definitely not: “Should I make a medication decision from a YouTube video?”
The better question is:
Does the reason I started still hold up?
That’s where longevity gets harder than just following protocols. A compound can be useful in one context and questionable in another. Something can make sense for one person, with one goal, at one stage of life, and not make sense for someone else.
That’s why copying someone else’s stack can become dangerous thinking.
Not necessarily dangerous because every item is bad, but dangerous because you may not know what problem each item is supposed to solve.
And if you don’t know why something is in your stack, you probably don’t know when it should come out.
The same issue shows up with baby aspirin.
Metformin feels like a longevity experiment. Baby aspirin feels familiar. A lot of people grew up hearing that low-dose aspirin was a smart preventive move for heart health. It seemed simple. It seemed normal. It seemed harmless.
But familiar doesn’t mean harmless.
Medical guidance changes as evidence changes. For some people, the risks of daily aspirin, especially bleeding risk, may outweigh the benefits. That doesn’t mean anyone should stop a medication because of a video. It means anything that affects your blood, your heart, your hormones, or your metabolism deserves a fresh conversation with your doctor.
That’s the kind of decision-making muscle longevity requires.
Then there are the things that appear to remain central to Sinclair’s world, like NMN and resveratrol.
These are tied to the ideas many people associate with his work: NAD, sirtuins, cellular aging, and the possibility of influencing how we age at a biological level. That’s why people pay attention. The theory is interesting. The mechanisms are interesting. The early data is interesting.
But promising is not the same as proven.
That distinction matters because the longevity space often sells possibility as certainty. It takes something that may be worth studying and turns it into something that feels like a guaranteed shortcut.
That’s where normal people can get into trouble.
You start with curiosity. Then a new protocol update drops. Then taurine sounds interesting. Fisetin sounds exciting. Alpha lipoic acid sounds practical. Suddenly you’re $150 deeper into supplements, and you still may not be able to explain what problem each one is solving for you.
That’s not a strategy.
That’s a shopping list with scientific vocabulary.
A better approach is to turn each new addition into a question.
Is taurine interesting enough to track?
Is fisetin too early to treat like a normal household protocol?
Is alpha lipoic acid solving a real problem for me, or does it just sound like a smart thing to add?
That’s the filter.
New doesn’t mean necessary. Interesting doesn’t mean urgent. And if you can’t explain what a supplement is supposed to do for you, it may not belong in your stack yet.
The uncomfortable truth is that most of us use trust as a shortcut.
We don’t have time to read every study, follow every trial, and rebuild every health decision from scratch. So we listen to smart people. We follow the breadcrumbs. We pay attention to people who seem disciplined, informed, and ahead of the curve.
That’s not foolish. That’s human.
But trust should be the starting point, not the finish line.
Because if the person you trust updates their thinking, and you don’t update yours, then you’re not following the data anymore. You’re following an old version of someone else’s confidence.
That’s the bigger lesson from Sinclair’s updated protocol.
Not that Metformin is bad.
Not that NMN is guaranteed.
Not that taurine is the next miracle.
The real lesson is that a longevity stack should be allowed to change.
And the question should always come back to this:
What still makes sense for me, with my body, my doctor, my goals, and the evidence we have right now?
That’s the kind of thinking we want for the Worldwide Tribe.
Not blind trust.
Not constant panic.
Not a cabinet full of things you can’t explain.
Just better questions, better decisions, and a health plan that actually belongs to you.
